ABBV - Company ID 0001551152
The table below shows AbbVie Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.77B | $6.57B | $9.39B | $5.63B | $6.47B | $5.17B |
| Short-term investments | - | - | - | $42.00M | $0.00 | $1.00M |
| Receivables | $13.51B | $13.82B | $12.48B | $12.77B | $12.64B | $12.48B |
| Inventory | $5.30B | $5.13B | $5.05B | $4.94B | $4.96B | $4.53B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $37.48B |
| $33.67B |
| $33.53B |
| $28.54B |
| $29.26B |
| $27.68B |
| Property, plant & equipment | $5.94B | $5.80B | $5.69B | $5.48B | $5.28B | $5.24B |
| Goodwill | $37.80B | $35.52B | $35.57B | $35.63B | $35.64B | $35.28B |
| Total assets | $147.68B | $135.12B | $136.46B | $133.90B | $137.18B | $136.16B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $43.10B | $41.64B | $42.10B | $39.39B | $39.77B | $36.40B |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$16.19B | -$17.33B | -$17.87B | -$14.23B | -$11.50B | -$9.53B |
| Total equity | -$4.58B | -$5.93B | -$6.66B | -$2.64B | -$183.00M | $1.42B |